Fundraising FoxPatients' & Consumers' Pharmaceutical
Centerville, US · Founded 2014 · Ohio corporation
Find your way into Patients' & Consumers' Pharmaceutical
Sign up to see every warm intro you have to Patients' & Consumers' Pharmaceutical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Patients' & Consumers' Pharmaceutical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MS
Michael SieronServes as Chief Operating Officer and President.
JB
Joseph B. D'SilvaExecutiveJoseph B. D'Silva has led pharmaceutical market research and strategy consulting for over 15 years, with engagements across 30+ brands at companies including Sanofi, Novartis, BMS, Pfizer, Genentech, and Regeneron. He recently directed commercialization strategy for JYNARQUE and holds an executive officer and director role at Patients' & Consumers' Pharmaceutical.
Board
BN
Brad NorrisBoard director
RE
Roger EdwardsBoard director
Reported raises · per SEC filings
Form D private placements$3.6M disclosed across 3 rounds · 2015–2018
▶$850KraisedJul 2018 · 8 investors · PharmaceuticalsRule 506(b)
▶$850KraisedJul 2018 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mike ShaneDirector
- Brent AtwoodExecutive Officer, Director
- Roger EdwardsExecutive Officer, Director
- Kent AndersonDirector
- Joseph B D'SilvaExecutive Officer, Director
- Brad M. NorrisDirector
- Offering amount
- $1.2M
- Amount sold
- $850K
- Proceeds to insiders
- $200K
- First sale
- Jul 2018
- Incorporated
- Corporation, Ohio, 2014
- Federal exemptions
- 06b
▶$2.2MraisedMay 2016 · 11 investors · Pharmaceuticals
▶$2.2MraisedMay 2016 · 11 investors · Pharmaceuticals
Officers, directors & promoters on the filing
- Michael SieronExecutive Officer
- Bradley M NorrisDirector
- Roger A EdwwardsDirector
- Kend AndersonDirector
- Joseph B D'SilvaExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2.2M
- Minimum investment
- $49.2K
- Proceeds to insiders
- $120K
- First sale
- May 2016
- Incorporated
- Corporation, Ohio, 2014
- Federal exemptions
- 05
▶$550KraisedFeb 2016 · 5 investors · Pharmaceuticals
▶$550KraisedFeb 2016 · 5 investors · Pharmaceuticals
Officers, directors & promoters on the filing
- Michael SieronExecutive Officer
- Joseph B. D'SilvaExecutive Officer, Director
- Brad NorrisDirector
- Roger EdwardsDirector
- Offering amount
- $550K
- Amount sold
- $550K
- Minimum investment
- $20K
- Proceeds to insiders
- $80K
- First sale
- May 2015
- Incorporated
- Corporation, Ohio, 2014
- Federal exemptions
- 05
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Patients' & Consumers' Pharmaceutical raised?
- Patients' & Consumers' Pharmaceutical has disclosed $3.6M raised across 3 rounds.
- Where is Patients' & Consumers' Pharmaceutical headquartered?
- Patients' & Consumers' Pharmaceutical is headquartered in Centerville, US.